https://www.selleckchem.com/pr....oducts/asunaprevir.h
1%, RR = 1.13, 95% CI = 0.87-1.47, P = .001). Begg correlation test and Egger regression test revealed no publication bias in this analysis. OSA is a salient factor in the progression or recurrence of AF. CPAP therapy for OSA may contribute to reduction of AF in patients for whom radiofrequency ablation or direct current cardioversion is not performed. The protocol for this meta-analysis was registered on PROSPERO with a registration No. CRD42019135229. The protocol for this meta-analysis was registered on PROSPERO with a registrati
Aimer
Commentaire
Partagez
